Bio-Imaging Rivals Lay Patent Claims To Rest
Caliper Life Sciences and AntiCancer Inc. have reached a cross-licensing deal for fluorescent imaging technology used to detect tumors, ending pending patent litigation between the bio-imaging rivals....To view the full article, register now.
Already a subscriber? Click here to view full article